#Obesity #PublicHealth #Italy #PrimaryCare #ITROSStudy #RealWorldEvidence #HealthcareInnovation #MedicalResearch #SSN To view or add a comment, sign in Please read**The article from Medical News Today links hypertension, heart disease, and other modifiable vascular/metabolic factors to increased dementia risk, emphasizing prevention through aggressive management to slow cognitive decline.[5]** ### Key Points - **Modifiable risk factors**: High blood pressure (hypertension), heart disease, and hyperlipidemia top the list
Hims approves quickly too and typically gets medication to you within about a week
"There are a lot of people who really don't want to take an injection
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) present a promising avenue for addressing the complex cardiovascular-kidney-metabolic health 11,12
Feel confident in your own skin
Cited by GLP-1 receptor agonists in adolescent obesity: Incretin-based therapies during a sensitive developmental period, Appetite, 227 , (108729), (2026)